Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China

INTRODUCTION: The invasive pneumococcal diseases (IPDs) caused by Streptococcus pneumoniae pose an enormous threat to children under 5 years of age. However, routine use of pneumococcal conjugate vaccines could aid in reducing the incidence of IPDs. The purpose of this clinical trial is to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing Jing, Yuan, Lin, Huang, Zhen, Shi, Nian Min, Zhao, Yu Liang, Xia, Sheng Li, Li, Guo Hua, Li, Rong Cheng, Li, Yan Ping, Yang, Shu Yuan, Xia, Jie Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Immunology (Including Allergy)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073664/
https://www.ncbi.nlm.nih.gov/pubmed/27798013
http://dx.doi.org/10.1136/bmjopen-2016-012488

Ejemplares similares

Ejemplares similares